Alnylam Pharmaceuticals
ALNY
#560
Rank
A$59.34 B
Marketcap
A$447.48
Share price
-1.75%
Change (1 day)
16.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company